Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Increased FDG-PET/CT pericardial uptake identifies acute pericarditis patients at high risk for relapse.

Gerardin C, Mageau A, Benali K, Jouan F, Ducrocq G, Alexandra JF, van Gysel D, Papo T, Sacre K.

Int J Cardiol. 2018 May 31. pii: S0167-5273(18)32412-4. doi: 10.1016/j.ijcard.2018.05.126. [Epub ahead of print]

PMID:
29884293
2.

Systemic inflammatory disorders in patients admitted for aseptic meningitis.

de la Motte MB, Abbas R, Jouan F, van Gysel D, Chauveheid MP, Papo T, Sacre K.

Clin Med (Lond). 2018 Mar;18(2):132-137. doi: 10.7861/clinmedicine.18-2-132.

PMID:
29626017
3.

Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs.

Pellefigues C, Dema B, Lamri Y, Saidoune F, Chavarot N, Lohéac C, Pacreau E, Dussiot M, Bidault C, Marquet F, Jablonski M, Chemouny JM, Jouan F, Dossier A, Chauveheid MP, Gobert D, Papo T, Karasuyama H, Sacré K, Daugas E, Charles N.

Nat Commun. 2018 Feb 20;9(1):725. doi: 10.1038/s41467-018-03129-8.

4.

Dual IRE1 RNase functions dictate glioblastoma development.

Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F, Bourien H, Logotheti M, Jégou G, Pallares-Lupon N, Schmit K, Le Reste PJ, Etcheverry A, Mosser J, Barroso K, Vauléon E, Maurel M, Samali A, Patterson JB, Pluquet O, Hetz C, Quillien V, Chatziioannou A, Chevet E.

EMBO Mol Med. 2018 Mar;10(3). pii: e7929. doi: 10.15252/emmm.201707929.

5.

The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13.

Hascoet P, Chesnel F, Jouan F, Le Goff C, Couturier A, Darrigrand E, Mahe F, Rioux-Leclercq N, Le Goff X, Arlot-Bonnemains Y.

Oncotarget. 2017 Jun 6;8(44):75989-76002. doi: 10.18632/oncotarget.18376. eCollection 2017 Sep 29.

6.

CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma.

Avril T, Etcheverry A, Pineau R, Obacz J, Jegou G, Jouan F, Le Reste PJ, Hatami M, Colen RR, Carlson BL, Decker PA, Sarkaria JN, Vauléon E, Chiforeanu DC, Clavreul A, Mosser J, Chevet E, Quillien V.

Clin Cancer Res. 2017 Dec 1;23(23):7360-7374. doi: 10.1158/1078-0432.CCR-17-1549. Epub 2017 Sep 22.

7.

CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice.

Poissonnier A, Sanséau D, Le Gallo M, Malleter M, Levoin N, Viel R, Morere L, Penna A, Blanco P, Dupuy A, Poizeau F, Fautrel A, Seneschal J, Jouan F, Ritz J, Forcade E, Rioux N, Contin-Bordes C, Ducret T, Vacher AM, Barrow PA, Flynn RJ, Vacher P, Legembre P.

Immunity. 2016 Jul 19;45(1):209-23. doi: 10.1016/j.immuni.2016.06.028.

8.

Le carcinome rénal à cellules claires (CRCC) sans altération du gène de Von Hippel-Lindau (VHL) : une entité anatomo-clinique à part ?

Brunot A, Dagher J, Perrin C, Patard JJ, Bensalah K, Verhoest G, Belaud-Rotureau M, Jouan F, Rioux-Leclercq N, Kammerer-Jacquet S.

Prog Urol. 2014 Nov;24(13):835. doi: 10.1016/j.purol.2014.08.114. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461641
9.

The von Hippel-Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform.

Chesnel F, Hascoet P, Gagné JP, Couturier A, Jouan F, Poirier GG, Le Goff C, Vigneau C, Danger Y, Verite F, Le Goff X, Arlot-Bonnemains Y.

Br J Cancer. 2015 Jul 14;113(2):336-44. doi: 10.1038/bjc.2015.189. Epub 2015 Jun 2.

10.

JC virus granule cell neuronopathy: A cause of infectious cerebellar degeneration.

Henry C, Jouan F, De Broucker T.

J Neurol Sci. 2015 Jul 15;354(1-2):86-90. doi: 10.1016/j.jns.2015.05.003. Epub 2015 May 9.

PMID:
26003226
11.

Sunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinoma.

Verhoest G, Dolley-Hitze T, Jouan F, Belaud-Rotureau MA, Oger E, Lavenu A, Bensalah K, Arlot-Bonnemains Y, Collet N, Rioux-Leclercq N, Vigneau C.

Biomed Res Int. 2014;2014:901371. doi: 10.1155/2014/901371. Epub 2014 May 22.

12.

Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.

Dagher J, Dugay F, Rioux-Leclercq N, Verhoest G, Oger E, Bensalah K, Cabillic F, Jouan F, Kammerer-Jacquet SF, Fergelot P, Vigneau C, Arlot-Bonnemains Y, Belaud-Rotureau MA.

Hum Pathol. 2014 Aug;45(8):1639-46. doi: 10.1016/j.humpath.2014.03.018. Epub 2014 Apr 18.

13.

[Renin-angiotensin system and urological cancers].

Verhoest G, Dolley-Hitze T, Jouan F, Bensalah K, Arlot-Bonnemains Y, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N, Vigneau C.

Prog Urol. 2014 Feb;24(2):73-9. doi: 10.1016/j.purol.2013.09.010. Epub 2013 Oct 16. Review. French.

14.

All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study.

Vigneau C, Lorcy N, Dolley-Hitze T, Jouan F, Arlot-Bonnemains Y, Laguerre B, Verhoest G, Goujon JM, Belaud-Rotureau MA, Rioux-Leclercq N.

Nephrol Dial Transplant. 2014 Feb;29(2):325-32. doi: 10.1093/ndt/gft465. Epub 2013 Dec 2.

PMID:
24302609
15.

Overexpression of the polarity protein PAR-3 in clear cell renal cell carcinoma is associated with poor prognosis.

Dugay F, Le Goff X, Rioux-Leclerq N, Chesnel F, Jouan F, Henry C, Cabillic F, Verhoest G, Vigneau C, Arlot-Bonnemains Y, Belaud-Rotureau MA.

Int J Cancer. 2014 May 1;134(9):2051-60.

16.

Identification of pVHL as a novel substrate for Aurora-A in clear cell renal cell carcinoma (ccRCC).

Martin B, Chesnel F, Delcros JG, Jouan F, Couturier A, Dugay F, Le Goff X, Patard JJ, Fergelot P, Vigneau C, Rioux-Leclerq N, Arlot-Bonnemains Y.

PLoS One. 2013 Jun 13;8(6):e67071. doi: 10.1371/journal.pone.0067071. Print 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/d506055a-d16b-4c0c-aef6-ad39e91a3b8d.

17.

A 70-year-old woman with acute chest pain and a paracardiac mass.

Jouan F, Sacre K, Debray MP, Crestani B, Chauveheid MP, Papo T.

Chest. 2013 Mar;143(3):866-869. doi: 10.1378/chest.12-1651. No abstract available.

PMID:
23460167
18.

[Angiotensin-2 type 1 receptors (AT1R) and cancers].

Dolley-Hitze T, Verhoest G, Jouan F, Le Pogamp P, Arlot-Bonnemains Y, Oger E, Belaud-Rotureau MA, Rioux-Leclercq N, Vigneau C.

Nephrol Ther. 2013 Apr;9(2):85-91. doi: 10.1016/j.nephro.2012.09.006. Epub 2013 Jan 14. Review. French.

PMID:
23332110
19.

Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.

Edeline J, Mottier S, Vigneau C, Jouan F, Perrin C, Zerrouki S, Fergelot P, Patard JJ, Rioux-Leclercq N.

Hum Pathol. 2012 Nov;43(11):1982-90. doi: 10.1016/j.humpath.2012.01.023. Epub 2012 May 22.

PMID:
22626276
20.

Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines.

Martin B, Edeline J, Patard JJ, Oger E, Jouan F, Boulanger G, Zerrouki S, Vigneau C, Rioux-Leclercq N.

J Cancer Res Clin Oncol. 2012 Jun;138(6):907-16. doi: 10.1007/s00432-012-1162-x. Epub 2012 Feb 10.

PMID:
22322364
21.

[The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].

Perrin C, Patard JJ, Jouan F, Collet N, Théoleyre S, Edeline J, Zerrouki S, Laguerre B, Bellaud-Roturaud MA, Rioux-Leclercq N, Vigneau C.

Prog Urol. 2011 Nov;21(12):851-8. doi: 10.1016/j.purol.2011.06.005. Epub 2011 Sep 3. French.

PMID:
22035911
22.

PPARγ is functionally expressed in clear cell renal cell carcinoma.

Collet N, Théoleyre S, Rageul J, Mottier S, Jouan F, Rioux-Leclercq N, Fergelot P, Patard JJ, Masson D, Denis MG.

Int J Oncol. 2011 Mar;38(3):851-7. doi: 10.3892/ijo.2010.891. Epub 2010 Dec 28.

PMID:
21206970
23.

Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?

Dolley-Hitze T, Jouan F, Martin B, Mottier S, Edeline J, Moranne O, Le Pogamp P, Belaud-Rotureau MA, Patard JJ, Rioux-Leclercq N, Vigneau C.

Br J Cancer. 2010 Nov 23;103(11):1698-705. doi: 10.1038/sj.bjc.6605866.

24.

Paraffin-embedded tissue is less accurate than frozen section analysis for determining VHL mutational status in sporadic renal cell carcinoma.

Verhoest G, Patard JJ, Fergelot P, Jouan F, Zerrouki S, Dreano S, Mottier S, Rioux-Leclercq N, Denis MG.

Urol Oncol. 2012 Jul-Aug;30(4):469-75. doi: 10.1016/j.urolonc.2010.07.005. Epub 2010 Sep 21.

25.

Loss of expression of TIMP3 in clear cell renal cell carcinoma.

Masson D, Rioux-Leclercq N, Fergelot P, Jouan F, Mottier S, Théoleyre S, Bach-Ngohou K, Patard JJ, Denis MG.

Eur J Cancer. 2010 May;46(8):1430-7. doi: 10.1016/j.ejca.2010.01.009. Epub 2010 Mar 1.

PMID:
20194016
26.

Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma.

Patard JJ, Rioux-Leclercq N, Masson D, Zerrouki S, Jouan F, Collet N, Dubourg C, Lobel B, Denis M, Fergelot P.

Br J Cancer. 2009 Oct 20;101(8):1417-24. doi: 10.1038/sj.bjc.6605298. Epub 2009 Sep 15.

27.

Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage.

Rebillard A, Rioux-Leclercq N, Muller C, Bellaud P, Jouan F, Meurette O, Jouan E, Vernhet L, Le Quément C, Carpinteiro A, Schenck M, Lagadic-Gossmann D, Gulbins E, Dimanche-Boitrel MT.

Oncogene. 2008 Nov 20;27(51):6590-5. doi: 10.1038/onc.2008.257. Epub 2008 Aug 4.

PMID:
18679423
28.

Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases.

Rioux-Leclercq N, Fergelot P, Zerrouki S, Leray E, Jouan F, Bellaud P, Epstein JI, Patard JJ.

Hum Pathol. 2007 Oct;38(10):1489-95. Epub 2007 Jun 26.

PMID:
17597181
29.

Development of the uterine shell glands during the preovulatory and early gestation periods in oviparous and viviparous Lacerta vivipara.

Heulin B, Stewart JR, Surget-Groba Y, Bellaud P, Jouan F, Lancien G, Deunff J.

J Morphol. 2005 Oct;266(1):80-93.

PMID:
16127704
30.

The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.

Rioux-Leclercq N, Leray E, Patard JJ, Lobel B, Guillé F, Jouan F, Bellaud P, Epstein JI.

Hum Pathol. 2005 May;36(5):531-5.

PMID:
15948120
31.

Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinoma.

Rioux-Leclercq N, Delcros JG, Bansard JY, Epstein JI, Patard JJ, Lobel B, Guillé F, Jouan F, Bellaud P, Moulinoux JP.

Hum Pathol. 2004 Oct;35(10):1279-84.

PMID:
15492997
32.
33.

[Biliary ileus. A very unusual form: duodenal calculi].

Couinaud C, Jouan F.

Arch Fr Mal App Dig. 1968 Jun;57(4):473-86. French. No abstract available.

PMID:
5741152
34.

[DIAPHRAGMATIC EVENTRATION: CLINICAL MANIFESTATION OF INJURY OF THE PHRENIC NERVE].

COUINAUD C, JOUAN F.

Ann Chir. 1963 Oct;12:1293-5. French. No abstract available.

PMID:
14093768
35.

[Gastritis. How is it recognized and treated?].

JOUAN F.

Vie Med. 1961;42(2):89-94. French. No abstract available.

PMID:
13790804
36.

[Effect of a medicinal nutritional aid in gallbladder and intestinal diseases].

JOUAN F.

Sem Med Prof Med Soc. 1959 Mar 20;35(11):301-3. French. No abstract available.

PMID:
13659019
37.

Contribution à l'étude du prolapsus rectal de l'enfant.

BENSAUDE A, JOUAN F, BERNARD G.

Presse Med. 1955 Nov 12;63(75):1533-4. French. No abstract available.

PMID:
13289582
38.

[Results obtained in oral angiocholegraphy with 4114 Th (vesipaque)].

Porcher P, Cottet J, Lehmann R, Jouan F.

Arch Mal Appar Dig Mal Nutr. 1954 Jul-Aug;43(7-8):828-33; discussion, 833-4. French. No abstract available.

PMID:
13198374
39.

[X-ray study of a new biliary contrast medium: 2-(2,4,6-triiodophenoxy)-butyric acid or 4114 TH].

LEHMANN R, JOUAN F, COTTET J.

Presse Med. 1954 Jan 27;62(6):123-4. Undetermined Language. No abstract available.

PMID:
13145543

Supplemental Content

Support Center